The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
News|Slideshows|February 28, 2025
Emerging Research and News in Prostate Cancer Imaging — February 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in February 2025.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from common contributing factors with false positives and false negatives on prostate MRI to a new meta-analysis on PET/CT radiotracers, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for February 2025.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Catch up on the top radiology content of the past week.
Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3
3
Diagnostic Imaging’s Weekly Scan: October 4 — October 10
4
What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment
5